Local treatment of vaginal infections of varying etiology with dequalinium chloride or povidone iodine: A randomised, double-blind, active-controlled, multicentric clinical study

Arzneimittel-Forschung/Drug Research

Volumn 52, Issue 9, 2002, Pages 706-715

  Petersen, Eiko E ^a   Weissenbacher, Ernst R ^a   Hengst, Peter ^a   Spitzbart, Heinz ^a   Weise, Wolfgang ^a   Wolff, Friedrich ^a   Dreher, Ekkehard ^a   Ernst, Uwe ^a   Della Casa, Vera ^a   Pohlig, Gabriele ^a   Graf, Federico ^a   Kaiser, R Renato ^a  

^a Medinova Ltd   (Switzerland)

Author keywords

CAS 25655 41 8; CAS 522 51 0; Dequalinium chloride; Fluomycin N ; Povidone iodine; Vaginal infections

Indexed keywords

DEQUALINIUM; FLUOMYCIN N; POVIDONE IODINE;

ADULT; AGED; ANTIBACTERIAL ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTITIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; TREATMENT OUTCOME; TRICHOMONIASIS; VAGINA BLEEDING; VAGINA CANDIDIASIS; VAGINITIS;

EID: 0036379408     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1299955     Document Type: Article

References (46)

1. Amsel, R., Totten, P. A., Spiegel, C. A. et al., Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiological associations. Am. J. Med. 74, 14 (1983)
2. Centers for Disease Control and Prevention, Guidelines for treatment of sexually transmitted diseases. Morbid. Mortal. Weekly Rep. 47, 70 (1998)
3. Livengood, C. H., Soper, D. E., Sheehan, K. L. et al., Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosis. Sex. Transm. Dis. 26, 137 (1999)
4. Schmitt, C., Sobel, J. D., Meriwether, C., Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole. Obstet. Gynecol. 79, 1020 (1992)
5. Hay, P. E., Recurrent bacterial vaginosis. Dermatol. Clin. 16, 769 (1998)
6. Sobel, J. D., Vaginitis, N. Eng. J. Med. 337, 1896 (1997)
7. Spinillo, A., Capuzzo, E., Gulminetti, R. et al., Prevalence of and risk factors for fungal vaginitis. Am. J. Obstet. Gynecol. 176, 138 (1997)
8. Dun, E., Antifungal resistance in yeast vaginitis. Yale J. Biol. Med. 72, 281 (2000)
9. Gray, L. A., Barnes, M. L., Vaginitis in women, diagnosis and treatment. Am. J. Obstet. Gynecol. 92, 125 (1965)
10. Donders, G. G. G., Odds, A., Vereecken, A. et al., Abnormal vaginal flora in the first trimester, but not fullblown bacterial vaginosis, is associated with preterm birth. Prenat. Neonat. Med. 3, 588 (1998)
11. Donders, G. G. G., Vereecken, A., Bosmans, E. et al., Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. Br. J. Obstet. Gynecol. 109, 34 (2002)
12. Collier, H. O. J., Cox, W. A., Huskinson, P. L., Further observations on the biological properties of dequalinium (Dequadyn) and hedaquinium (Teoquil). J. Pharm. Pharmacol. 11, 671 (1959)
13. D'Auria, F. D., Simonetti, G., Strippoli, V., Caratteristiche antimicrobiche di una tintura al dequalinio cloruro. Ann. Ig. 1, 1227 (1989)
14. Della Casa, V., Noll, H., Gonser, S. et al., Antimicrobial activity of dequalinium chloride against leading germs of vaginal infections. Arzneim.-Forsch./Drug Res. 52, 699 (2002)
15. Marianos, J. J., Quaternary ammonium antimicrobial compounds, In: S. S. Block (ed.), Disinfection, sterilization and preservation, 4th ed., p. 225-255. Lea & Febiger, Philadelphia (1991)
16. Levinson, D. R., Dequalinium in the treatment of trichomoniasis in women. Practitioner 183, 195 (1959)
17. Atlante, G., Un nuovo chemioterapico nella terapia delle vaginiti da trichomonas e da candida. Minverva Ginecol. 11, 588 (1959)
18. Martin, R., Lokales Therapeutikum bei mykotischen und bakteriellen Kolpitiden gut bewährt. Med. Tribune 37, 8 (1971)
19. Lange, K., Medikamentöse Behandlung des infektiösen Fluors. Ärztl. Praxis 23, 4153 (1971)
20. Mühlbauer, W., Behandlung des infektiösen Fluors mit Dequavagyn. Therapiewoche 22, 1414 (1972)
21. Kolbe, H., Zur Behandlung des infektiösen vaginalen Fluors mit Dequavagyn. Ther. Gegenwart 111, 415 (1972)
22. Kucera, H., Kupka, S., Zur Behandlung des infektiösen Fluors durch Dequaliniumchlorid und seiner Kombination mit verschiedenen Östriolkomponenten. Wien. Med. Wochenschr. 123, 683 (1973)
23. Moayer, M., Feldmann, H. U., "Gewöhnliche" vaginale Mischinfektionen. gyne, January 1980
24. Bianco, V., Minorchio, E., Biraghi, P. et al., Impiego di una associazione di dequalinium, tirotrichina e idrocortisone in lavanda nella terapia delle cervico vaginity: studio clinico controllato. Ann. Ost. Gin. Med. Perin. CV, 260 (1984)
25. Strecker, M., Kokemohr, H., Teucher, T. et al., Antiseptika gegen Vulvovaginitiden. TW Gynäkologie 6, 409 (1993)
26. Meyer-Rohn, J., Liehr, W., Experimentelle Untersuchungen zur Wirkung eines jodhaltigen Breitband-Antiseptikums auf Bakterien und Dermatophyten. Infection 4, 215 (1976)
27. König, B., Reimer, K., Fleischer, W. et al., Effects of Betaisodona on parameters of host defense. Dermatology 195, 42 (1997)
28. Carrol, B., Keosian, J., Steinman, I. D., The mode of action of iodine on infectious agents. J. Newark Beth.-Israel Hosp. 6, 129 (1955)
29. Gershenfeld, L., Povidone-iodine (PVP-I) as a trichomonacide. Am. J. Pharm. 134, 324 (1962)
30. Gershenfeld, L., Povidone-iodine (PVP-I) as a vaginal microbicide. Am. J. Pharm. 134, 278 (1962)
31. Shook, D. M., A clinical study of a povidone-iodine regimen for resistant vaginitis. Curr. Ther. Res. 5, 256 (1963)
32. Harris, P. G., Clinical experience with povidone-iodine vaginal pessaries in the treatment of non-specific vaginitis. Practitioner 1254, 828 (1972)
33. Maneksha, S., Comparison of Povidone-Iodine (Betadine) vaginal pessaries and lactic acid pessaries in the treatment of vaginitis. J. Int. Med. Res. 2, 236 (1974)
34. Henderson, J. N., Tait, I. B., The use of povidone-iodine (Betadine) pessaries in the treatment of candidal and trichomonal vaginitis. Curr. Med. Res. Opin. 3, 157 (1975)
35. Duran, A. A., Latis, P. L., Clinical experience with Betadine microbicides in the treatment of vaginitis of mixed etiology. In: H. Reber (ed.), World Congress on Antisepsis, p. 65-68. HP Publishing, New York (1978)
36. Resch, B. A., Szanto, F., Local treatment of colpitis with Betadine vaginal suppository. Ther. Hung. 41, 137 (1993)
37. Gimes, G., Peter, F., Clinical significance of betadine vaginal suppository treatment in pregnancy. Acta Pharm. Hung. 67, 249 (1997)
38. Schroeder, K., Zur Pathogenese und Klinik des vaginalen Fluors. Zentralbl. Gynäkol. 38, 1350 (1921)
39. Cohen, J., Statistical Power Analysis for the Behavioral Sciences. Academic Press, New York (1969)
40. Colditz, G. A., Miller, J. N., Mosteller, F., Measuring gain in the evaluation of medical technology. The probability of a better outcome. Int. J. Technol. Assess Health Care 4, 637 (1988)
41. Adam, D., Antibakterielle Chemotherapie mit Antibiotika. In: H. P. Kuemmerle, G. Hitzenberger, K. H. Spitzy (eds.), Klinische Pharmakologie pp. 1-67. Ecomed Verlag, Landsberg (1989)
42. Quan, M., Vaginitis: meeting the clinical challenge. Clin. Cornerstone 3, 36 (2000)
43. McGregor, J. A., French, J. I., Bacterial vaginosis in pregnancy. Obstet. Gynecol. Surv. 55, 1 (2000)
44. McDonald, H. M., O'Loughlin, J. A., Jolley, P. et al., Vaginal infection in preterm labour. Br. J. Obstet. Gynaecol. 98, 427 (1991)
45. Donders, G. G. G., Treatment of sexually transmitted bacterial diseases in pregnant women. Drugs 59, 477 (2000)
46. Braun-Falco, O., Lukacs, I., Die Dequalinium-Nekrose. Dtsch. Med. Wochenschr. 95, 1115 (1970)